Worldquant Millennium Advisors LLC Buys New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Worldquant Millennium Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,401 shares of the medical equipment provider's stock, valued at approximately $1,775,000.

Other hedge funds have also added to or reduced their stakes in the company. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares in the last quarter. Truist Financial Corp grew its position in Intuitive Surgical by 3.0% during the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after buying an additional 7,298 shares in the last quarter. Global X Japan Co. Ltd. increased its stake in Intuitive Surgical by 9.8% during the 4th quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock worth $24,161,000 after acquiring an additional 4,140 shares during the period. Finally, Affinity Wealth Management LLC raised its holdings in Intuitive Surgical by 13.4% in the 4th quarter. Affinity Wealth Management LLC now owns 7,952 shares of the medical equipment provider's stock valued at $4,151,000 after acquiring an additional 939 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 2.0%

ISRG traded up $10.58 on Tuesday, reaching $550.12. The stock had a trading volume of 742,672 shares, compared to its average volume of 1,643,430. The company has a market capitalization of $197.17 billion, a price-to-earnings ratio of 85.77, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The firm has a 50-day moving average of $512.50 and a 200-day moving average of $538.12.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the previous year, the business posted $1.50 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at $271,397.94. This trade represents a 63.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock valued at $16,865,621 in the last ninety days. 0.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Barclays reduced their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Evercore ISI reduced their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.